Swiss National Bank Sells 4,200 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Swiss National Bank decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 583,100 shares of the company's stock after selling 4,200 shares during the period. Swiss National Bank owned approximately 0.23% of HCA Healthcare worth $236,989,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of HCA. Capital World Investors increased its position in shares of HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company's stock worth $931,342,000 after acquiring an additional 1,019,750 shares in the last quarter. Darsana Capital Partners LP increased its position in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock worth $369,472,000 after acquiring an additional 400,000 shares in the last quarter. TD Asset Management Inc boosted its holdings in HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company's stock worth $238,110,000 after purchasing an additional 19,812 shares during the last quarter. Epoch Investment Partners Inc. boosted its holdings in HCA Healthcare by 16.4% during the second quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company's stock worth $203,002,000 after purchasing an additional 88,948 shares during the last quarter. Finally, National Pension Service boosted its holdings in HCA Healthcare by 11.9% during the third quarter. National Pension Service now owns 550,654 shares of the company's stock worth $223,802,000 after purchasing an additional 58,353 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Down 2.1 %

Shares of HCA stock traded down $7.07 on Monday, hitting $335.89. 1,496,181 shares of the company's stock traded hands, compared to its average volume of 1,187,725. The stock has a market capitalization of $85.08 billion, a price-to-earnings ratio of 15.40, a P/E/G ratio of 1.32 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company's fifty day simple moving average is $385.11 and its 200 day simple moving average is $357.92. HCA Healthcare, Inc. has a one year low of $245.03 and a one year high of $417.14.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.79%. HCA Healthcare's dividend payout ratio (DPR) is 11.85%.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of research analyst reports. TD Cowen dropped their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research note on Friday, August 23rd. Leerink Partners boosted their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an "outperform" rating in a research note on Wednesday, July 24th. Morgan Stanley started coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 price target on the stock. Finally, Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research note on Monday, August 19th. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $385.00.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company's stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 over the last 90 days. Company insiders own 1.60% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.